Literature DB >> 9164599

Influenza virus infection of mice induces anorexia: comparison with endotoxin and interleukin-1 and the effects of indomethacin.

A H Swiergiel1, G N Smagin, A J Dunn.   

Abstract

The effects of infection of mice with influenza virus on ingestive behavior were assessed by both 22-h intake of food pellets, and intake of sweetened milk in a 30-minute access period. Infection with a lethal dose of virus resulted in losses in body weight as well as a reduction in food pellet intake. By contrast, infection with a sublethal dose of virus decreased body weight and food pellet intake to a lesser extent, but did not alter milk intake. Acute intraperitoneal injection of endotoxin (LPS, 0.3-5 micrograms), interleukin-1 alpha (IL-1 alpha, 50-100 ng) or IL-1 beta (100 ng) reduced milk intake, suggesting that the reduction of ingestive behavior may be associated with immune activation in general, and IL-1 in particular Pretreatment of the mice with the cyclooxygenase inhibitor, indomethacin (10 mg/kg SC) substantially attenuated, but did not completely reverse, the reduction in milk intake by LPS and IL-1. However, chronic treatment with indomethacin failed to alter the body weight or the intake of sweetened milk in influenza-infected mice, although there was some attenuation of the reduction in food intake. These results suggest that although IL-1 may play a role in the anorexia caused by influenza virus infection, it is not the only factor involved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164599     DOI: 10.1016/s0091-3057(96)00335-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  19 in total

1.  Respiratory Viral Infection Alters the Gut Microbiota by Inducing Inappetence.

Authors:  Miriam F Moffatt; Michael J Cox; John S Tregoning; Helen T Groves; Sophie L Higham
Journal:  mBio       Date:  2020-02-18       Impact factor: 7.867

2.  Physiological and behavioral responses to interleukin-1beta and LPS in vagotomized mice.

Authors:  Marek Wieczorek; Artur H Swiergiel; Hossein Pournajafi-Nazarloo; Adrian J Dunn
Journal:  Physiol Behav       Date:  2005-07-21

3.  Reduced ingestion of sweetened milk induced by interleukin-1 and lipopolysaccharide is associated with induction of cyclooxygenase-2 in brain endothelia.

Authors:  Adrian J Dunn; Artur H Swiergiel; Hao Zhang; Ning Quan
Journal:  Neuroimmunomodulation       Date:  2006-10-17       Impact factor: 2.492

4.  Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats.

Authors:  Richard De La Garza; Gregory M Asnis; Kevin R Fabrizio; Erika Pedrosa
Journal:  Psychopharmacology (Berl)       Date:  2004-11-25       Impact factor: 4.530

5.  Feeding, exploratory, anxiety- and depression-related behaviors are not altered in interleukin-6-deficient male mice.

Authors:  Artur H Swiergiel; Adrian J Dunn
Journal:  Behav Brain Res       Date:  2006-05-03       Impact factor: 3.332

6.  The olfactory nerve has a role in the body temperature and brain cytokine responses to influenza virus.

Authors:  Victor H Leyva-Grado; Lynn Churchill; Joseph Harding; James M Krueger
Journal:  Brain Behav Immun       Date:  2009-10-29       Impact factor: 7.217

7.  Effects of cytokines and infections on brain neurochemistry.

Authors:  Adrian J Dunn
Journal:  Clin Neurosci Res       Date:  2006-08

8.  Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory.

Authors:  Ja Wook Koo; Ronald S Duman
Journal:  Neurosci Lett       Date:  2009-03-27       Impact factor: 3.046

9.  Maternal immune activation alters fetal brain development through interleukin-6.

Authors:  Stephen E P Smith; Jennifer Li; Krassimira Garbett; Karoly Mirnics; Paul H Patterson
Journal:  J Neurosci       Date:  2007-10-03       Impact factor: 6.167

10.  Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests.

Authors:  Artur H Swiergiel; Adrian J Dunn
Journal:  Pharmacol Biochem Behav       Date:  2007-02-16       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.